Top companies

ASIANPAINT - 2253.3 (-0.31%) AXISBANK - 964.15 (-0.62%) BAJAJFINSV - 1719.7 (0.16%) BAJFINANCE - 7286.95 (-0.06%) BHARTIARTL - 1630.2 (0.25%) BPCL - 275.45 (-1.7%) COALINDIA - 376.6 (-1.3%) HDFCBANK - 1645.05 (0.16%) HEROMOTOCO - 4047.25 (0.56%) HINDUNILVR - 2347 (0.28%) ICICIBANK - 1196.15 (0%) INDUSINDBK - 953.25 (-0.75%) ITC - 438 (0.1%) KOTAKBANK - 1892.35 (-0.05%) MARUTI - 12046.5 (1.37%) ONGC - 262.65 (-1.19%) RELIANCE - 1271.95 (-0.14%) SBIN - 745.8 (-1.75%) TATAMOTORS - 737.5 (-3.06%) TATASTEEL - 127.54 (-1.67%) TCS - 4125 (2.21%) TITAN - 3360.3 (0.21%) WIPRO - 304.75 (2.15%)

Quick Menu

TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

The page of SPARC. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 22-01-2025 is predicted based on technical analysis and should only be used as reference for learning purpose only.

Sector: Pharmaceuticals

Sun Pharma Advanced Research Company Limited

174.92   -2.09 (-1.18%)

As on 22 Jan, 2025 13:28 IST
Open 177.5
LTP 174.92
Previous Close 177.01
Day High 178.87
Day Low 173.15
Volume 278172

SPARC Prediction / Intraday Stock Price Target

Disclaimer :- Intraday Stock & Index Prediction Levels are been generated everyday at 17:00 Hours for the next trading day. Stock or Index Prediction is done based on technical & strategic levels of the stock or index & can only be used as reference for study of charts & volume patterns. GrowMudra strictly recommends everyone to consult a certified financial advisor before initiating any trade in the stock market. GrowMudra strictly forbids anyone to take the above views as advisory & holds no responsibility on any financial losses or gain.

Peers

Company Name Price Change % Chg Day High Day Low Previous Close Volume
Sun Pharma Advanced Research Company Limited 0 0 0 0 0 0 0
Syncom Healthcare Limited 0 0 0 0 0 0 0

About Company

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.

 

Top Gainers

Company LTP Change Gain
Tata-Consultancy-Services-Limited 4125 89.15 2.21 %
Wipro 304.75 6.4 2.15 %

Top Losers

Company LTP Change Loss
Tata-Motors-Limited 737.5 -23.25 -3.06 %
State-Bank-of-India 745.8 -13.25 -1.75 %

Growmudra © 2025 all right reserved

Partner With Us